Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

[Pentamer guided HLA-restricted epitope identification for mucoprotein 4 antigen of pancreatic ductal adenocarcinoma].

Gao WT, Zhang JJ, Zhu Y, Wei JS, Meng K, Chen JM, Wu JL, Miao Y.

Zhonghua Wai Ke Za Zhi. 2010 Sep 15;48(18):1416-24. Chinese.

PMID:
21092580
2.

Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy.

Wu J, Wei J, Meng K, Chen J, Gao W, Zhang J, Xu Z, Miao Y.

Immunopharmacol Immunotoxicol. 2009;31(3):468-76. doi: 10.1080/08923970902795203.

PMID:
19555216
3.

Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.

Peiper M, Goedegebuure PS, Alldinger I, Knoefel WT, Izbicki JR, Eberlein TJ.

Anticancer Res. 2002 Nov-Dec;22(6A):3357-63.

PMID:
12530087
4.

Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer.

Shichijo S, Azuma K, Komatsu N, Ito M, Maeda Y, Ishihara Y, Itoh K.

Clin Cancer Res. 2004 Sep 1;10(17):5828-36.

5.

Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells.

Peiper M, Goedegebuure PS, Eberlein TJ.

Surgery. 1997 Aug;122(2):235-41; discussion 241-2.

PMID:
9288128
6.

[Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66].

Jin S, Wang Y, Wang SJ, Zhang HZ, Li MX, Chen Y, Ge HL.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Mar;21(2):233-6, 242. Chinese.

PMID:
15766414
7.

An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N, Sato N.

Clin Cancer Res. 2002 Jun;8(6):1731-9.

8.

The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes.

Peiper M, Goedegebuure PS, Linehan DC, Ganguly E, Douville CC, Eberlein TJ.

Eur J Immunol. 1997 May;27(5):1115-23.

PMID:
9174600
9.

Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TRAG-3 antigen.

Zhu B, Chen Z, Cheng X, Lin Z, Guo J, Jia Z, Zou L, Wang Z, Hu Y, Wang D, Wu Y.

Clin Cancer Res. 2003 May;9(5):1850-7.

10.

[Prediction synthesis and identification of HLA-A2-restricted cytotoxic T lymphocyte epitopes of the tumor antigen MAGE-n].

Dong HL, Sui YF, Ye J, Li ZS, Qu P, Zhang XM, Chen GS, Lu SY.

Zhonghua Yi Xue Za Zhi. 2003 Jun 25;83(12):1080-3. Chinese.

PMID:
12899783
11.

Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen delivery.

Robson NC, McAlpine T, Knights AJ, Schnurr M, Shin A, Chen W, Maraskovsky E, Cebon J.

Blood. 2010 Jul 15;116(2):218-25. doi: 10.1182/blood-2009-10-249458. Epub 2010 Apr 29.

12.

Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes.

Tamura M, Nishizaka S, Maeda Y, Ito M, Harashima N, Harada M, Shichijo S, Itoh K.

Jpn J Cancer Res. 2001 Jul;92(7):762-7.

PMID:
11473727
13.

The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.

Adair SJ, Carr TM, Fink MJ, Slingluff CL Jr, Hogan KT.

J Immunother. 2008 Jan;31(1):7-17.

PMID:
18157007
14.

Identification of novel survivin-derived CTL epitopes.

Reker S, Meier A, Holten-Andersen L, Svane IM, Becker JC, thor Straten P, Andersen MH.

Cancer Biol Ther. 2004 Feb;3(2):173-9. Epub 2004 Feb 1.

PMID:
14726703
15.

Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer.

Yamazoe S, Tanaka H, Iwauchi T, Yoshii M, Ito G, Amano R, Yamada N, Sawada T, Ohira M, Hirakawa K.

Pancreas. 2011 Aug;40(6):896-904. doi: 10.1097/MPA.0b013e31821ad8d1.

PMID:
21697763
16.

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.

Schmidt SM, Schag K, Müller MR, Weck MM, Appel S, Kanz L, Grünebach F, Brossart P.

Blood. 2003 Jul 15;102(2):571-6. Epub 2003 Feb 6.

17.

Cross-presentation of NY-ESO-1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells.

Susumu S, Nagata Y, Ito S, Matsuo M, Valmori D, Yui K, Udono H, Kanematsu T.

Cancer Sci. 2008 Jan;99(1):107-12. Epub 2007 Nov 7.

18.
19.

The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.

Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M.

J Immunol. 2004 May 1;172(9):5249-61.

20.

The renal cell carcinoma-associated antigen G250 encodes a human leukocyte antigen (HLA)-A2.1-restricted epitope recognized by cytotoxic T lymphocytes.

Vissers JL, De Vries IJ, Schreurs MW, Engelen LP, Oosterwijk E, Figdor CG, Adema GJ.

Cancer Res. 1999 Nov 1;59(21):5554-9.

Supplemental Content

Support Center